Literature DB >> 18009960

THE USE OF CONVALESCENT HUMAN SERUM IN INFLUENZA PNEUMONIA-A PRELIMINARY REPORT.

L W McGuire, W R Redden.   

Abstract

Entities:  

Year:  1918        PMID： 18009960      PMCID： PMC1362336          DOI： 10.2105/ajph.8.10.741

Source DB:  PubMed          Journal:  Am J Public Health (N Y)        ISSN： 0271-4353


× No keyword cloud information.
  17 in total

1.  The convalescent sera option for containing COVID-19.

Authors:  Arturo Casadevall; Liise-Anne Pirofski
Journal:  J Clin Invest       Date:  2020-04-01       Impact factor: 14.808

2.  Serial Convalescent Plasma Infusions for the Initial COVID-19 Infections in the Appalachian Region of West Virginia.

Authors:  Brian P Peppers; Aaron Shmookler; Johnathan Stanley; Lisa Giblin Sutton; Peter L Perrotta; Theodore Kieffer; David Skoner; Stacey Mahady; Callum Lewandrowski; Heath Damron; Alexander Horspool; Ankit Sakhjua; Paul McCarthy; Robert W Hostoffer
Journal:  Allergy Rhinol (Providence)       Date:  2022-06-30

3.  What are protective antibody responses to pandemic SARS-CoV-2?

Authors:  Jeffrey P Henderson
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

4.  Early mortality benefit with COVID-19 convalescent plasma: a matched control study.

Authors:  Aarthi G Shenoy; Aaron Z Hettinger; Stephen J Fernandez; Joseph Blumenthal; Valentina Baez
Journal:  Br J Haematol       Date:  2021-01-22       Impact factor: 6.998

Review 5.  Modalities and Mechanisms of Treatment for Coronavirus Disease 2019.

Authors:  Zhihong Zuo; Ting Wu; Liangyu Pan; Chenzhe Zuo; Yingchuo Hu; Xuan Luo; Liping Jiang; Zanxian Xia; Xiaojuan Xiao; Jing Liu; Mao Ye; Meichun Deng
Journal:  Front Pharmacol       Date:  2021-02-08       Impact factor: 5.810

Review 6.  Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates.

Authors:  Henu Kumar Verma; Batoul Farran; Lakkakula V K S Bhaskar
Journal:  Antib Ther       Date:  2020-05-27

Review 7.  Potential strategies for combating COVID-19.

Authors:  Saba Shamim; Maryam Khan; Zelal Jaber Kharaba; Munazza Ijaz; Ghulam Murtaza
Journal:  Arch Virol       Date:  2020-08-10       Impact factor: 2.574

8.  Enhanced IL-1β production is mediated by a TLR2-MYD88-NLRP3 signaling axis during coinfection with influenza A virus and Streptococcus pneumoniae.

Authors:  Angeline E Rodriguez; Christopher Bogart; Christopher M Gilbert; Jonathan A McCullers; Amber M Smith; Thirumala-Devi Kanneganti; Christopher R Lupfer
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

Review 9.  Ebola virus convalescent blood products: where we are now and where we may need to go.

Authors:  Thierry Burnouf; Jerard Seghatchian
Journal:  Transfus Apher Sci       Date:  2014-10       Impact factor: 1.764

Review 10.  Regenerative Medicine in COVID-19 Treatment: Real Opportunities and Range of Promises.

Authors:  Arefeh Basiri; Zahra Pazhouhnia; Nima Beheshtizadeh; Mahdieh Hoseinpour; Amene Saghazadeh; Nima Rezaei
Journal:  Stem Cell Rev Rep       Date:  2021-02       Impact factor: 5.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.